CompoAtlas

Complexe-CL

Complexe-CL, licence 80031811: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
les Laboratoires Améa Ltée
NPN or DIN-HM
80031811
Status
Active licence
Licence date
28 April 2012
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Aesculus hippocastanum

Source : Graine(s)

Extraction ratio : 5000:1

Dry plant equivalent : 250 mg

50.0 mgNot calculated
Vaccinium myrtillus

Source : Fruit

Extraction ratio : 5000:1

Dry plant equivalent : 250 mg

50.0 mgNot calculated

Non-medicinal ingredients

Stéarate de magnésium, Dioxyde de silicium, Maltodextrine, Hydroxypropylméthylcellulose, Extrait de vin

PopulationAgeQuantity per servingFrequency
AdultesNot specified1.0 Capsule4.0 Tous les jours

Uses authorised in Canada

Utilisé en phytothérapie comme astringent pour aider à soulager les symptômes liés qux varices tels que la lourdeur et la douleur aux jambes. Utilisé en phytothérapie pour aider à traiter les insuffisances veineuses chroniques et les symptômes qui accompagnent.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80031811

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line